Abstract
Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Current Enzyme Inhibition
Title: Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?
Volume: 7 Issue: 2
Author(s): Vaclava Bauerova, Zuzana Vinterova, Iva Pichova and Olga Hruskova-Heidingsfeldova
Affiliation:
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Abstract: Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Export Options
About this article
Cite this article as:
Bauerova Vaclava, Vinterova Zuzana, Pichova Iva and Hruskova-Heidingsfeldova Olga, Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?, Current Enzyme Inhibition 2011; 7 (2) . https://dx.doi.org/10.2174/157340811796575263
DOI https://dx.doi.org/10.2174/157340811796575263 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stem Cell Genetic Therapy for Fanconi Anemia – A New Hope
Current Gene Therapy Editorial:
Current Immunology Reviews (Discontinued) Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases
CNS & Neurological Disorders - Drug Targets Gossypium herbaceam L. Extracts Ameliorate Disequilibrium of IL- 1RA/IL-1β Ratio to Attenuate Inflammatory Process induced by Amyloid β in Rats
Current Alzheimer Research Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Studies of Substituted 1, 2, 3, 4- Tetrahydro Pyrimidine Phosphorus Derivatives
Combinatorial Chemistry & High Throughput Screening Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets SNew Trends in the Development of Opioid Peptide Analogues as Advanced Remedies for Pain Relief
Current Topics in Medicinal Chemistry Antiangiogenic Therapy for High-Grade Gliomas
CNS & Neurological Disorders - Drug Targets Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Management of Early Stage Chronic Myeloid Leukemia: State-of-the-art Approach and Future Perspectives
Current Cancer Drug Targets Population Studies of Association Between Lithium and Risk of Neurodegenerative Disorders
Current Alzheimer Research Methylone and Monoamine Transporters: Correlation with Toxicity
Current Neuropharmacology Neuroprotective Role of Nanoparticles Against Alzheimer's Disease
Current Drug Metabolism Role of Dimerization in Dopamine D<sub>4</sub> Receptor Biogenesis
Current Protein & Peptide Science Comparison of Status Epilepticus Models Induced by Pilocarpine and Nerve Agents - A Systematic Review of the Underlying Aetiology and Adopted Therapeutic Approaches
Current Medicinal Chemistry Sex Steroids Regulation of Appetitive Behavior
Mini-Reviews in Medicinal Chemistry Obesity and Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets